Delticom AG (DEX)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 2.260 |
|---|---|
| 52-week range | 1.920 – 2.920 |
| Return, 1 month / 3 months | −0.9% / +0.0% |
| Return, 1 year / 3 years | +7.7% / +28.2% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 49.9% |
| Worst drawdown (1 year) | -25.0% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Delticom AG runs online shops that sell tyres and wheels to motorists and business customers. Its web stores offer tyres for cars, motorcycles and commercial vehicles, along with related products and services such as fitting partners and delivery to customers. The company is based in Hanover, Germany, and serves customers in many European markets through its internet retailing operations.
Delticom AG trades under the code DEX on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Delticom AG (DEX) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 2.260 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 463 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.7% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.9% | ||
| From 52-week high | -21.0% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -7.5% | ||
| 12-month return, skipping the last month | 8.6% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.0% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | −0.9% |
| 3 months | +0.0% |
| 6 months | −7.5% |
| 1 year | +7.7% |
| 3 years | +28.2% |
| 5 years | −71.2% |
Signals
| 50-day / 200-day average | 2.238 / 2.303 |
|---|---|
| Golden / death cross (60 days) | Death, 28 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.062 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jul 2026 | EUR 0.1200 |
| 10 Jul 2025 | EUR 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.